View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
A recently identified gene may help clinicians fine-tune warfarin doses more quickly and precisely, according to a new study. Because warfarin has a narrow therapeutic window, many patients must undergo months of titration to achieve their ideal dosage.
Researchers believe that variations in the gene encoding vitamin K epoxide reductase complex 1 (VKORC1) explain why appropriate warfarin doses vary widely among patients. They found that Asian-Americans were more likely to have the low-dose VKORC1 gene, European Americans the intermediate-dose gene, and African-Americans the high-dose gene. Screening for VKORC1 variations could help improve warfarin dosing, but the researchers say more studies are needed first.
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose, The New England Journal of Medicine, MJ Rieder, et al., June 2, 2005.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top